The UDP glucuronosyltransferase (UGT) family of enzymes, which includes UGT2B4, serves a vital role in the metabolism and excretion of a myriad of substances. UGT2B4, in particular, is involved in the glucuronidation process, a biochemical reaction that attaches glucuronic acid to substrates, thereby enhancing their solubility and facilitating their elimination from the body. This enzyme is primarily hepatic, but it can also be found in other tissues, and it acts on a diverse array of compounds including endogenous substances like hormones and xenobiotics such as various environmental pollutants. The activity and expression of UGT2B4 can be influenced by numerous factors, including the presence of specific chemical activators that can upregulate its gene expression.
Several chemical compounds have been identified that can potentially serve as activators of UGT2B4 expression. Phenobarbital, for instance, is one such compound that can induce the enzyme's production by engaging with the constitutive androstane receptor, a nuclear receptor that, upon activation, binds to DNA regulatory regions and promotes the transcription of detoxification enzymes like UGT2B4. Another example is rifampicin, which operates through a similar mechanism involving the pregnane X receptor, a key regulator of genes implicated in the body's response to organic substances. Other activators such as omeprazole and clofibrate work through different pathways, such as the constitutive androstane receptor and peroxisome proliferator-activated receptors, respectively. These activators can significantly impact the expression levels of UGT2B4, highlighting the enzyme's role in a complex network of biological processes dedicated to maintaining cellular homeostasis in the face of diverse environmental chemicals.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin may induce UGT2B4 expression by acting as an agonist to the pregnane X receptor (PXR), a key transcriptional regulator for genes involved in xenobiotic metabolism. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole has the potential to stimulate UGT2B4 expression through indirect activation of the constitutive androstane receptor (CAR), which governs the expression of certain metabolic enzymes. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate can increase UGT2B4 levels by serving as an agonist to peroxisome proliferator-activated receptors (PPARs), which are nuclear receptors that promote the transcription of genes encoding metabolic enzymes. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
Chrysin might stimulate the expression of UGT2B4 through the activation of nuclear receptors that are involved in the body’s detoxification processes, leading to higher levels of this enzyme. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $612.00 | 4 | |
Benzo[a]pyrene can induce the expression of UGT2B4 by activating the aryl hydrocarbon receptor (AhR), which then enhances the transcription of genes coding for detoxification enzymes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may increase UGT2B4 expression by acting on glucocorticoid receptors (GR), which can bind to specific DNA sequences and boost the transcription of metabolic genes. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid has the capacity to stimulate UGT2B4 expression, potentially through the activation of nuclear factor erythroid 2–related factor 2 (Nrf2), which is involved in oxidative stress response. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might increase the expression of UGT2B4, potentially by activating sirtuin 1 (SIRT1), which has been implicated in the regulation of genes involved in metabolism. | ||||||
Naringenin | 480-41-1 | sc-219338 | 25 g | $245.00 | 11 | |
Naringenin can induce UGT2B4 expression possibly by its interaction with estrogen receptors, which can lead to enhanced gene transcription of enzymes involved in steroid metabolism. | ||||||
Tangeretin | 481-53-8 | sc-202826 | 10 mg | $422.00 | ||
Tangeretin may upregulate UGT2B4 by interacting with cell signaling pathways that govern the transcription of drug-metabolizing enzymes, although the exact mechanism is not fully understood. | ||||||